These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38058449)

  • 21. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.
    Nainys J; Lasickiene R; Petraityte-Burneikiene R; Dabrisius J; Lelesius R; Sereika V; Zvirbliene A; Sasnauskas K; Gedvilaite A
    BMC Biotechnol; 2014 Dec; 14():100. PubMed ID: 25487652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
    Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Porcine Circovirus (PCV) Genotype 2d-Based Virus-like Particles (VLPs) Induced Broad Cross-Neutralizing Antibodies against Diverse Genotypes and Provided Protection in Dual-Challenge Infection of a PCV2d Virus and a Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV).
    Kang SJ; Bae SM; Lee HJ; Jeong YJ; Lee MA; You SH; Lee HS; Hyun BH; Lee N; Cha SH
    Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the Efficacy and Cross-Protective Immunity of Live-Attenuated Chimeric PCV1-2b Vaccine Against PCV2b and PCV2d Subtype Challenge in Pigs.
    Huan C; Fan M; Cheng Q; Wang X; Gao Q; Wang W; Gao S; Liu X
    Front Microbiol; 2018; 9():455. PubMed ID: 29599761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli.
    Yin S; Sun S; Yang S; Shang Y; Cai X; Liu X
    Virol J; 2010 Jul; 7():166. PubMed ID: 20646322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral vaccination with the porcine circovirus type 2 (PCV-2) capsid protein expressed by Lactococcus lactis induces a specific immune response against PCV-2 in mice.
    Wang L; Zhao D; Sun B; Yu M; Wang Y; Ru Y; Jiang Y; Qiao X; Cui W; Zhou H; Li Y; Xu Y; Tang L
    J Appl Microbiol; 2020 Jan; 128(1):74-87. PubMed ID: 31574195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Truncated Diphtheria Toxin DT390 Enhances the Humoral Immunogenicity of Porcine Circovirus Type 2 Capsid Antigen in Mice.
    Chang XX; Fan K; Meng W; Guo J; Zhao D; Yin W; Li H; Wang Z
    Viral Immunol; 2021 Sep; 34(7):448-456. PubMed ID: 33902339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replacing the decoy epitope of PCV2 capsid protein with epitopes of GP3 and/or GP5 of PRRSV enhances the immunogenicity of bivalent vaccines in mice.
    Jung BK; Kim HR; Jang H; Chang KS
    J Virol Methods; 2020 Oct; 284():113928. PubMed ID: 32650038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2.
    Li Y; Wang Y; Cheng J; Zhou X; Lu H; Zhang X; Xia X; Sun H
    Virol J; 2020 Jun; 17(1):72. PubMed ID: 32517704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimal Dosage of Porcine Circovirus Type 2d Based Virus-like Particles to Induce Stable Protective Immunity against Infection.
    Baek JH; Cha SH; Cho SH; Lee MS; Park C
    Pathogens; 2021 Dec; 10(12):. PubMed ID: 34959599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.
    Wang YP; Liu D; Guo LJ; Tang QH; Wei YW; Wu HL; Liu JB; Li SB; Huang LP; Liu CM
    Vaccine; 2013 Jan; 31(5):833-8. PubMed ID: 23219694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cross-immunity among major porcine circovirus type 2 genotypes by infection with PCV2b and PCV2d circulating strains.
    Yu C; Cao M; Wei Y; Liu J; Zhang H; Liu C; Feng L; Huang L
    Vet Microbiol; 2023 Aug; 283():109796. PubMed ID: 37285792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a
    Tseng YH; Hsieh CC; Kuo TY; Liu JR; Hsu TY; Hsieh SC
    Indian J Microbiol; 2019 Dec; 59(4):490-499. PubMed ID: 31762513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A candidate DNA vaccine encoding a fusion protein of porcine complement C3d-P28 and ORF2 of porcine circovirus type 2 induces cross-protective immunity against PCV2b and PCV2d in pigs.
    Hou Z; Wang H; Feng Y; Li Q; Li J
    Virol J; 2019 May; 16(1):57. PubMed ID: 31046793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD40 Ligand and GMCSF Coexpression Enhance the Immune Responses and Protective Efficacy of PCV2 Adenovirus Vaccine.
    Li D; Huang Y; Du Q; Wang Z; Chang L; Zhao X; Tong D
    Viral Immunol; 2016 Apr; 29(3):148-58. PubMed ID: 26982652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.
    Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA
    Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological Analysis From 2018 to 2020 in China and Prevention Strategy of Porcine Circovirus Type 2.
    Huang Y; Chen X; Long Y; Yang L; Song W; Liu J; Li Q; Liang G; Yu D; Huang C; Tang X
    Front Vet Sci; 2021; 8():753297. PubMed ID: 34869727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.
    Wang Y; Lu Y; Liu D; Wei Y; Guo L; Wu H; Huang L; Liu J; Liu C
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1155-63. PubMed ID: 25487886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of adenovirus vaccines expressing the PCV2 capsid protein in pigs.
    Li D; Du Q; Wu B; Li J; Chang L; Zhao X; Huang Y; Tong D
    Vaccine; 2017 Aug; 35(36):4722-4729. PubMed ID: 28755834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice.
    Sylla S; Cong YL; Sun YX; Yang GL; Ding XM; Yang ZQ; Zhou YL; Yang M; Wang CF; Ding Z
    Microbiol Immunol; 2014 Jul; 58(7):398-408. PubMed ID: 24845706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.